Veeva Systems has built its presence in brand engagement with the acquisition of Ostro, a tech start-up that helps pharma companies connect with doctors and patients using AI-powered conversational ...

Veeva Systems, which offers life sciences companies cloud-based commercial management software and business consulting services, is venturing into the consumer-facing side of things with the ...

Fiscal Year 2026 Total Revenues of $3,195.3M, up 16% Year Over Year Q4 Total Revenues of $836.0M, up 16% Year Over Year Fiscal Year 2026 Subscription Revenues of $2,684.2M, up 17% Year Over Year Q4 ...

Surpassed the $3 billion revenue run rate goal in fiscal 2025, driven by deep strategic partnerships and innovation across the life sciences sector. Performance attribution for the year was ...

The deal signals Veeva’s push to expand artificial intelligence tools that help pharmaceutical brands interact with patients and healthcare professionals. The transaction adds an AI-powered engagement ...

CEO Peter Gassner stated, "We had a strong finish to the year, delivering results ahead of our guidance. Total revenue in the quarter was $836 million with non-GAAP operating income of $366 million.

Weeping Peninsula (South Limgrave) - Dungeons, Points of Interest, and Secrets East Liurnia - Dungeons, Points of Interest, and Secrets North Liurnia - Dungeons, Points of Interest, and Secrets West ...

In the rapidly evolving landscape of the life sciences industry, artificial intelligence (AI) is moving away from experimentation and taking its place as a strategic asset to biopharmas. However, for ...

Shares of cloud-based software company Veeva Systems Inc VEEV are rocketing higher on Wednesday after reporting fourth-quarter financial results and providing guidance. • Veeva Systems shares are ...

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the ...

Software stocks have taken a beating lately—but Veeva Systems looks well-placed to weather the market’s fears about artificial-intelligence disruption. Shares in the life sciences cloud solutions ...